Reshaping American tobacco policy: eight proposals for the Trump administration

Many variations, all much safer than cigarettes – but what does FDA/CDC do about that?

Welcome to a new report written by me, Clive Bates, with David Sweanor of Ottawa University, and Eli Lehrer, President of the R Street Institute. The fully designed report is available at R Street with press notice.

Reshaping American […]

The wilful ignorance of tobacco control McCarthyites

Just when you thought public health could sink no lower, it pulls it off again! This time, a couple of “tobacco control” organisations, CTFK and ENSP, have been writing to several participants in a conference (GTNF 2016) to be held next week. The letters tell them they must be mistaken, that they can’t possibly […]

Death by paperwork: consultation on EU e-cigarette notification regime

Death by paperwork: no estimate has been made of the damage that paperwork burdens will do

Under the Tobacco Products Directive Article 20(2), e-cigarette and e-liquid manufacturers or importers will have to notify the authorities of any product they want to place on the market. A low-key (to put it mildly) UK consultation […]

Misleading the public for their own good? Changing the warnings on snus

Misleading labels implicitly exaggerating risk? These are the current U.S. snus warnings

What sort of ‘warnings’ should go on tins of snus? Modern snus use is probably around 98% less risky than smoking – but do the regulatory ‘risk communications’ in the form of these warnings really reflect that? Do they give the consumer […]

Wells Fargo second annual e-cig conference – some reflections

The switch to 2nd generation products arrested the decline of NJOY

I participated as a panel member in the Wells Fargo Securities Second Annual E-cig Conference, chaired by Bonnie Herzog, the lead beverage and tobacco sector analyst at Wells Fargo. It was a fascinating occasion and good moment to take the temperature of the […]

Big Pharma anti-vaping ad complaint

I found this annoying and decided to complain

Update: MHRA (predictably) rejected this complaint. So, medicine regulator defends regulated medicine maker in attack on non-medical but superior alternative to smoking. To do otherwise would have been to draw attention to the folly of regulating recreational nicotine products as medicines. See letter (PDF). End of […]

Regulation for tobacco harm reduction – four pillars

 

In my last post on regulation I set out some general ideas that I think should guide and constrain the regulation of e-cigarettes. From my presentation at Global Forum on Nicotine in Warsaw, here’s a suggested four pillars for regulation of e-cigarettes and other low risk products.

[…]

E-cigs and regulation – what do investment analysts think?

The investment analysts are always interesting on tobacco and e-cigs, and in a usefully dispassionate ‘follow-the-money’ kind of way.

Here’s a small collection of quotes I’ve seen in recent analyst reports mainly as they relate to regulation of e-cigarettes. I don’t see all reports of course so this is necessarily selective. For ease of reference, […]

E-cigs: man talks sense

Dave Dorn of VapourTrails TV – an e-cigarette user and enthusiast – explains e-cigs and goes through some commonly held misconceptions.

[…]

Reduce harm or protect the cigarette industry? Briefing to MEPs for European Parliament public hearing

European Parliament: heading for an own goal?

On Monday 25th February 2013, the European Parliament committee that is scrutinising the proposed EU Tobacco Products Directive holds a public hearing, and take evidence from invited witnesses. The committee is the Environment, Public Health and Food Safety Committee (known as ENVI). This post provides links to […]